GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Tidal Investments LLC

Tidal Investments LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,974 shares of the company’s stock after selling 2,753 shares during the quarter. Tidal Investments LLC’s holdings in GE HealthCare Technologies were worth $3,997,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in GEHC. California State Teachers Retirement System boosted its position in GE HealthCare Technologies by 2.2% during the 1st quarter. California State Teachers Retirement System now owns 682,116 shares of the company’s stock valued at $62,011,000 after purchasing an additional 14,800 shares during the period. B. Riley Wealth Advisors Inc. increased its holdings in shares of GE HealthCare Technologies by 17.0% during the first quarter. B. Riley Wealth Advisors Inc. now owns 7,404 shares of the company’s stock valued at $673,000 after purchasing an additional 1,074 shares during the period. Jacobs Levy Equity Management Inc. raised its stake in shares of GE HealthCare Technologies by 4,959.8% during the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after purchasing an additional 743,523 shares in the last quarter. Janus Henderson Group PLC lifted its stake in shares of GE HealthCare Technologies by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 834,278 shares of the company’s stock worth $75,832,000 after acquiring an additional 89,400 shares during the period. Finally, Kennedy Capital Management LLC raised its holdings in GE HealthCare Technologies by 23.3% during the first quarter. Kennedy Capital Management LLC now owns 156,183 shares of the company’s stock worth $14,199,000 after purchasing an additional 29,543 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jan Makela sold 66,955 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total value of $5,459,510.70. Following the sale, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,165,395.92. The disclosure for this sale can be found here. Insiders sold a total of 90,482 shares of company stock valued at $7,369,137 in the last quarter. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price on the stock. Bank of America decreased their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Finally, Mizuho dropped their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $94.09.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded down $0.76 on Friday, reaching $82.64. The stock had a trading volume of 113,647 shares, compared to its average volume of 3,118,759. The stock has a market cap of $37.72 billion, a P/E ratio of 24.39, a price-to-earnings-growth ratio of 3.04 and a beta of 1.17. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The business’s 50-day moving average price is $78.84 and its two-hundred day moving average price is $82.33.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.76% and a net margin of 8.10%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $0.92 earnings per share. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.